Kevin Koch

Kevin Koch is a Venture Partner with OrbiMed Advisors, LLC, and the President and CEO of Edgewise Therapeutics. He was formerly at Biogen as Senior Vice President of Drug Discovery: Chemical and Molecular Therapeutics, where he managed global drug discovery and the immunology and hematology teams. Previously, Kevin Koch served as the President, CSO, Board member and Co-Founder of Array BioPharma, where he oversaw the invention of over 20 clinical development candidates in multiple therapeutic areas. Prior to Array, Kevin Koch held senior positions at Amgen Inc. and Pfizer Central Research. He is the co-author or inventor of multiple patents and publications and received his PhD in Organic Chemistry from University of Rochester.